DSKYF:OTCMKTS
Daiichi Sankyo Co Ltd
$17.69
0.00%
(0.00) 1D
$17.09
arrow_downward
-3.40% (-0.60)todayPre-market
Closed: Oct 6, 3:40:15 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DSKYF...
Mkt. cap
31.65B
Avg. vol.
2.68K
Volume
4.90K
52-wk high
$29.15
52-wk low
$13.85
Beta
-1.13
Shares outstanding
1.86B
No. of employees
20K
Mkt. cap
31.65B
Avg. vol.
2.68K
Volume
4.90K
52-wk high
$29.15
52-wk low
$13.85
Beta
-1.13
Shares outstanding
1.86B
No. of employees
20K
News stories
From web sources and news partners
Simply Wall Street
·
7 hours ago
Cancer Trial Tie Up Might Change The Case For Investing In Daiichi Sankyo (TSE:4568)
AD HOC NEWS
·
15 hours ago
Daiichi Sankyo stock faces setback after I-DXd filing withdrawal
AD HOC NEWS
·
2 days ago
Daiichi Sankyo expands Datroway trials: what it means for Daiichi Sankyo stock
Profile
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent.
Daiichi Sankyo, Inc. began operating in the U.S. in 2006. It is the U.S. subsidiary of Daiichi Sankyo Company, Limited, and a member of the Daiichi Sankyo Group. The organization, which includes U.S. commercial operations and global clinical development, is headquartered in Basking Ridge, New Jersey.
Daiichi Sankyo Europe, GmbH, the European subsidiary, is headquartered in Munich, Germany. The organization is responsible for development and manufacturing for 12 European countries.
Daiichi Sankyo Company, Limited is a full member of the European Federation of Pharmaceutical Industries and Associations and of the International Federation of Pharmaceutical Manufacturers and Associations. Wikipedia
About Daiichi Sankyo Co Ltd
CEOHiroyuki Okuzawa
Employees20.2K
FoundedSep 28, 2005
HeadquartersChuo City, Tokyo, Japan
Sector-
Websitedaiichisankyo.co.jp